| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |